or therapeutic medical strategies. However, the ESC Guidelines do not override in any way
whatsoever the individual responsibility of health professionals to make appropriate and …

Summary Each year, the American Heart Association (AHA), in conjunction with the National
Institutes of Health and other government agencies, brings together in a single document the …

The recommendations listed in this clinical practice guideline are, whenever possible,
evidence-based. An initial extensive evidence review, which included literature derived from …

Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports on the most up-to-date statistics related to heart disease, stroke …

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and
the Prevention of Sudden Cardiac Death: A Report of the American College of …

The single most common cause of the withdrawal or restriction of the use of marketed drugs
has been QT-interval prolongation associated with polymorphic ventricular tachycardia, or …

Background Left ventricular dysfunction after myocardial infarction is associated with an
increased risk of death. Other studies have suggested that a potassium-channel blocker …

however, this characteristic twisting morphology may not be evident in all ECG leads.
Second, episodes of drug-induced TdP usually start with a short-long-short pattern of RR …

Cardiac arrhythmias are among the leading causes of mortality. They often arise from
alterations in the electrophysiological properties of cardiac cells and their underlying ionic …

A novel potassium channel gene has been cloned, characterized, and associated with
cardiac arrhythmia. The gene encodes MinK-related peptide 1 (MiRP1), a small integral …